<DOC>
	<DOCNO>NCT01888250</DOCNO>
	<brief_summary>This open label , randomise , balance , two-treatment , two-period , two-sequence , single dose , crossover , oral bioequivalence study .</brief_summary>
	<brief_title>Bioequivalence Study Lamotrigine Extended-Release Tablets 200mg Under Fasting Condition</brief_title>
	<detailed_description>An open label , balance , randomize , two-treatment , two-period , two-sequence , single dose , crossover , oral bioequivalence study Lamotrigine Extended Release tablets 200mg Dr. Reddy 's Laboratories Limited , India compare LAMICTAL XR ( contain Lamotrigine ) Extended Release tablet 200mg GlaxoSmithKline Research Triangle Park , NC healthy , adult , human subject fast condition .</detailed_description>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Subjects select base follow inclusion criterion : Provide write informed consent . Must healthy , adult , human being within 18 45 year age ( inclusive ) weigh least 50 kg . Having body mass index 18.5 24.9 ( inclusive ) , calculate weight Kg/height 2 . Must normal health determine medical history , physical examination laboratory investigation perform within 28 day prior commencement study . ( Laboratory value must within normal limit consider physician / investigator clinical significance ) . Female Subjects Of child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . Surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject ) Exclusion Criteria The subject exclude base follow criterion screen study : Incapable understanding informed consent . Systolic blood pressure le 90 mm Hg 140 mm Hg . Diastolic blood pressure le 60 mm Hg 90 mm Hg . Oral temperature 95.0°F 98.6°F . Pulse rate 50/min 100/min . History hypersensitivity idiosyncratic reaction investigational drug product relate drug ingredient . Any evidence impairment renal , hepatic , cardiac , lung gastrointestinal function . Consumption grapefruit past ten day prior checkin , period . Regular smoker habit smoke nine cigarette per day difficulty abstain smoke sample collection period . Habit tobacco chew . Habit alcoholism difficulty abstain alcohol sample collection period . Difficulty abstain xanthine contain food beverage ( like tea , coffee , chocolates cola drink ) sample collection period . Intake counter ( OTC ) prescribe medication enzyme modify medication systemic medication last 30 day dose . Clinically significant abnormality / significant disease . Confirmed positive alcohol screening . Confirmed positive urine cotinine test . Confirmed positive select drug abuse . Participated clinical investigation use experimental drug/donated blood past 90 day date start study . Confirmed positive urine pregnancy test . xx . Female detect pregnant , breast feeding likely become pregnant study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Lamotrigine Extended Release</keyword>
	<keyword>crossover</keyword>
</DOC>